Refine
Year of publication
Document Type
- Article (68)
- In Proceedings (6)
- ZIB-Annual (2)
- Doctoral Thesis (1)
- In Collection (1)
- ZIB-Report (1)
Is part of the Bibliography
- no (79)
Keywords
- Jahresbericht (2)
- KOBV (2)
- ANFIS (1)
- ANN (1)
- Cross-validation (1)
- Disease severity (1)
- Epidemiology (1)
- Infectious Diseases (1)
- MODIS (1)
- Microbiology (1)
The evolution of many dynamical systems that describe relationships or interactions between objects can be effectively modeled by temporal networks, which are typically represented as a sequence of static network snapshots. In this paper, we introduce a novel random walk based approach that can identify clusters of time-snapshots in which network community structures are stable. This allows to detect significant structural shifts over time, such as the splitting, merging, birth, or death of communities. We also provide a low-dimensional representation of entire snapshots, placing those with similar community structure close to each other in the feature space. To validate our approach, we develop an agent-based algorithm that generates synthetic datasets with the desired characteristic properties, enabling thorough testing and benchmarking. We further demonstrate the effectiveness and broad applicability of our technique by testing it on various social dynamics models and real-world datasets and comparing its performance to several state-of-the-art algorithms. Our findings highlight the strength of our approach to correctly capture and analyze the dynamics of complex systems.
Epithelial mesenchymal transition (EMT) process has been shown as highly relevant to cancer prognosis. However, although different biological network-based biomarker identification methods have been proposed to predict cancer prognosis, EMT network has not been directly used for this purpose. In this study, we constructed an EMT regulatory network consisting of 87 molecules and tried to select features that are useful for prognosis prediction in Lung Adenocarcinoma (LUAD). To incorporate multiple molecular profiles, we obtained four types of molecular data including mRNA-Seq, copy number alteration (CNA), DNA methylation, and miRNA-Seq data from The Cancer Genome Atlas. The data were mapped to the EMT network in three alternative ways: mRNA-Seq and miRNA-Seq, DNA methylation, and CNA and miRNA-Seq. Each mapping was employed to extract five different sets of features using discretization and network-based biomarker identification methods. Each feature set was then used to predict prognosis with SVM and logistic regression classifiers. We measured the prediction accuracy with AUC and AUPR values using 10 times 10-fold cross validation. For a more comprehensive evaluation, we also measured the prediction accuracies of clinical features, EMT plus clinical features, randomly picked 87 molecules from each data mapping, and using all molecules from each data type. Counter-intuitively, EMT features do not always outperform randomly selected features and the prediction accuracies of the five feature sets are mostly not significantly different. Clinical features are shown to give the highest prediction accuracies. In addition, the prediction accuracies of both EMT features and random features are comparable as using all features (more than 17,000) from each data type.
Motivation: High-throughput proteomics techniques, such as mass spectrometry
(MS)-based approaches, produce very high-dimensional data-sets. In a clinical
setting one is often interested how MS spectra dier between patients of different
classes, for example spectra from healthy patients vs. spectra from patients
having a particular disease. Machine learning algorithms are needed to (a)
identify these discriminating features and (b) classify unknown spectra based on
this feature set. Since the acquired data is usually noisy, the algorithms should be
robust to noise and outliers, and the identied feature set should be as small as
possible.
Results: We present a new algorithm, Sparse Proteomics Analysis (SPA), based
on the theory of Compressed Sensing that allows to identify a minimal
discriminating set of features from mass spectrometry data-sets. We show how
our method performs on artificial and real-world data-sets.
Educating parents about the vaccination status of their children: A user-centered mobile application
(2017)
Parents are often uncertain about the vaccination status of their children. In times of vaccine hesitancy, vaccination programs could benefit from active patient participation. The Vaccination App (VAccApp) was developed by the Vienna Vaccine Safety Initiative, enabling parents to learn about the vaccination status of their children, including 25 different routine, special indication and travel vaccines listed in the WHO Immunization Certificate of Vaccination (WHO-ICV). Between 2012 and 2014, the VAccApp was validated in a hospital-based quality management program in Berlin, Germany, in collaboration with the Robert Koch Institute. Parents of 178 children were asked to transfer the immunization data of their children from the WHO-ICV into the VAccApp. The respective WHO-ICV was photocopied for independent, professional data entry (gold standard). Demonstrating the status quo in vaccine information reporting, a Recall Group of 278 parents underwent structured interviews for verbal immunization histories, without the respective WHO-ICV. Only 9% of the Recall Group were able to provide a complete vaccination status; on average 39% of the questions were answered correctly. Using the WHO-ICV with the help of the VAccApp resulted in 62% of parents providing a complete vaccination status; on average 95% of the questions were answered correctly. After using the VAccApp, parents were more likely to remember key aspects of the vaccination history. User-friendly mobile applications empower parents to take a closer look at the vaccination record, thereby taking an active role in providing accurate vaccination histories. Parents may become motivated to ask informed questions and to keep vaccinations up-to-date.
One of the most widely recognized features of biological systems is their modularity. The modules that constitute biological systems are said to be redeployed and combined across several conditions, thus acting as building blocks. In this work, we analyse to what extent are these building blocks reusable as compared with those found in randomized versions of a system. We develop a notion of decompositions of systems into phenotypic building blocks, which allows them to overlap while maximizing the number of times a building block is reused across several conditions. Different biological systems present building blocks whose reusability ranges from single use (e.g. condition specific) to constitutive, although their average reusability is not always higher than random equivalents of the system. These decompositions reveal a distinct distribution of building block sizes in real biological systems. This distribution stems, in part, from the peculiar usage pattern of the elements of biological systems, and constitutes a new angle to study the evolution of modularity.